Relative roles of TGF-β1 and Wnt in the systemic regulation and aging of satellite cell responses

Aging Cell

Volumn 8, Issue 6, 2009, Pages 676-689

  Carlson, Morgan E ^a   Conboy, Michael J ^a   Hsu, Michael ^a   Barchas, Laurel ^a   Jeong, Jaemin ^a   Agrawal, Anshu ^b   Mikels, Amanda J ^c   Agrawal, Smita ^d   Schaffer, David V ^d   Conboy, Irina M ^a  

^a University of California at Berkeley   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

^d University of California   (United States)

Author keywords

Aging; Anti aging; Cytokines; Skeletal muscle

Indexed keywords

NEUTRALIZING ANTIBODY; PHOSPHOTRANSFERASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WNT PROTEIN;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLIC REGULATION; MOLECULAR INTERACTION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE SATELLITE CELL; ANIMAL; C57BL MOUSE; CELL AGING; CELL COMMUNICATION; CELL CULTURE; HUMAN; METABOLISM; SKELETAL MUSCLE; STEM CELL;

MUS;

AGING; ANIMALS; CELL AGING; CELL COMMUNICATION; CELLS, CULTURED; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEINS;

EID: 74049132357     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2009.00517.x     Document Type: Article

References (61)

1. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB (1994) An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284.
2. Andrews ZB, Zhao H, Frugier T, Meguro R, Grattan DR, Koishi K, McLennan IS (2006) Transforming growth factor beta2 haploinsufficient mice develop age-related nigrostriatal dopamine deficits. Neurobiol. Dis. 21, 568-575.
3. Annes JP, Munger JS, Rifkin DB (2003) Making sense of latent TGFbeta activation. J. Cell Sci. 116, 217-224.
4. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258, 7155-7160.
5. Bonyadi M, Rusholme SA, Cousins FM, Su HC, Biron CA, Farrall M, Akhurst RJ (1997) Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat. Genet. 15, 207-211.
6. Brack AS, Rando TA (2007) Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev. 3, 226-237.
7. Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ, Keller C, Rando TA (2007) Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science (New York, NY) 317, 807-810.
8. Brack AS, Conboy IM, Conboy MJ, Shen J, Rando TA (2008) A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2, 50-59.
9. Brand T, MacLellan WR, Schneider MD (1993) A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain. J. Biol. Chem. 268, 11500-11503.
10. Brionne TC, Tesseur I, Masliah E, Wyss-Coray T (2003) Loss of TGFbeta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 1133-1145.
11. Carlson ME, Conboy IM (2007a) Loss of stem cell regenerative capacity within aged niches. Aging Cell 6, 371-382.
12. Carlson ME, Conboy IM (2007b) Regulating the Notch pathway in embryonic, adult and old stem cells. Curr. Opin. Pharmacol. 7, 303-309.
13. Carlson BM, Faulkner JA (1989) Muscle transplantation between young and old rats: age of host determines recovery. Am. J. Physiol. 256, C1262-C1266.
14. Carlson ME, Hsu M, Conboy IM (2008) Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 454, 528-532.
15. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, Partridge TA, Morgan JE (2005) Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289-301.
16. Conboy IM, Rando TA (2002) The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3, 397-409.
17. Conboy IM, Conboy MJ, Smythe GM, Rando TA (2003) Notch-mediated restoration of regenerative potential to aged muscle. Science (New York, NY) 302, 1575-1577.
18. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760-764.
19. Danielpour D, Kim KY, Dart LL, Watanabe S, Roberts AB, Sporn MB (1989) Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) in complex biological fluids. Growth Factors 2, 61-71.
20. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF (1999) Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 19, 2495-2504.
21. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584.
22. Dorshkind K, Montecino-Rodriguez E, Signer RA (2009) The ageing immune system: is it ever too old to become young again? Nat. Rev. 9, 57-62.
23. Dunker N, Krieglstein K (2000) Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267, 6982-6988.
24. Feng XH, Derynck R (2005) Specificity and versatility in TGF-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693.
25. Gellibert F, Woolven J, Fouchet MH, Mathews N, Goodland H, Lovegrove V, Laroze A, Nguyen VL, Sautet S, Wang R, Janson C, Smith W, Krysa G, Boullay V, De Gouville AC, Huet S, Hartley D (2004) Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. J. Med. Chem. 47, 4494-4506.
26. Grounds MD (1998) Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann. N.Y. Acad. Sci. 854, 78-91.
27. Grounds MD (2002) Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling. Biogerontology 3, 19-24.
28. Hyytiainen M, Penttinen C, Keski-Oja J (2004) Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit. Rev. Clin. Lab. Sci. 41, 233-264.
29. Ignowski JM, Schaffer DV (2004) Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells. Biotechnol. Bioeng. 86, 827-834.
30. Ikeya M, Takada S (1998) Wnt signaling from the dorsal neural tube is required for the formation of the medial dermomyotome. Development (Cambridge, England) 125, 4969-4976.
31. Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH, ten Dijke P (2003) Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J. Biol. Chem. 278, 3751-3761.
32. Kamanga-Sollo E, Pampusch MS, White ME, Dayton WR (2003) Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-beta- and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures. J. Cell. Physiol. 197, 225-231.
33. Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M, Moon RT (2004) Mutant Frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. Nat. Cell Biol. 6, 52-58.
34. Kundu SD, Kim IY, Yang T, Doglio L, Lang S, Zhang X, Buttyan R, Kim SJ, Chang J, Cai X, Wang Z, Lee C (2000) Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-beta type II dominant negative receptor. Prostate 43, 118-124.
35. Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, Leveen P, Xu X, ten Dijke P, Mummery CL, Karlsson S (2001) Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20, 1663-1673.
36. Le Grand F, Jones AE, Seale V, Scime A, Rudnicki MA (2009) Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell stem cell 4, 535-547.
37. Li Y, Foster W, Deasy BM, Chan Y, Prisk V, Tang Y, Cummins J, Huard J (2004) Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am. J. Pathol. 164, 1007-1019.
38. Marom K, Fainsod A, Steinbeisser H (1999) Patterning of the mesoderm involves several threshold responses to BMP-4 and Xwnt-8. Mech. Dev. 87, 33-44.
39. Massague J (1987) The TGF-beta family of growth and differentiation factors. Cell 49, 437-438.
40. Massague J (1998) TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
41. Massague J, Chen YG (2000) Controlling TGF-beta signaling. Genes Dev. 14, 627-644.
42. Mauro A (1961) Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9, 493-495.
43. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387, 83-90.
44. Moresi V, Pristera A, Scicchitano BM, Molinaro M, Teodori L, Sassoon D, Adamo S, Coletti D (2008) Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response. Stem cells (Dayton, Ohio) 26, 997-1008.
45. Muller B, Hartmann B, Pyrowolakis G, Affolter M, Basler K (2003) Conversion of an extracellular Dpp/BMP morphogen gradient into an inverse transcriptional gradient. Cell 113, 221-233.
46. Oshima M, Oshima H, Taketo MM (1996) TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297-302.
47. Renault V, Thornell LE, Eriksson PO, Butler-Browne G, Mouly V (2002) Regenerative potential of human skeletal muscle during aging. Aging Cell 1, 132-139.
48. Schultz E, Lipton BH (1982) Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech. Ageing Dev. 20, 377-383.
49. Shah AH, Tabayoyong WB, Kimm SY, Kim SJ, Van Parijs L, Lee C (2002) Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease. J. Immunol. 169, 3485-3491.
50. Shen W, Li Y, Zhu J, Schwendener R, Huard J (2008) Interaction between macrophages, TGF-beta1, and the COX-2 pathway during the inflammatory phase of skeletal muscle healing after injury. J. Cell. Physiol. 214, 405-412.
51. Sherwood RI, Christensen JL, Conboy IM, Conboy MJ, Rando TA, Weissman IL, Wagers AJ (2004) Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 119, 543-554.
52. Shi DL, Bourdelas A, Umbhauer M, Boucaut JC (2002) Zygotic Wnt/beta-catenin signaling preferentially regulates the expression of Myf5 gene in the mesoderm of Xenopus. Dev. Biol. 245, 124-135.
53. Singh J, Chuaqui CE, Boriack-Sjodin PA, Lee WC, Pontz T, Corbley MJ, Cheung HK, Arduini RM, Mead JN, Newman MN, Papadatos JL, Bowes S, Josiah S, Ling LE (2003) Successful shape-based virtual screening: the discovery of a potent inhibitor of the type I TGFbeta receptor kinase (TbetaRI). Bioorg. Med. Chem. Lett. 13, 4355-4359.
54. Tang P, Jasser SA, Sung JC, Shi Y, Steck PA, Yung WK (1999) Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth. J. Neurooncol. 43, 127-135.
55. Wagers AJ, Conboy IM (2005) Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122, 659-667.
56. Wagner J, Schmidt C, Nikowits W Jr, Christ B (2000) Compartmentalization of the somite and myogenesis in chick embryos are influenced by wnt expression. Dev. Biol. 228, 86-94.
57. Wharton SJ, Basu SP, Ashe HL (2004) Smad affinity can direct distinct readouts of the embryonic extracellular Dpp gradient in Drosophila. Curr. Biol. 14, 1550-1558.
58. Wyss-Coray T, Borrow P, Brooker MJ, Mucke L (1997) Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J. Neuroimmunol. 77, 45-50.
59. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, Mucke L (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-618.
60. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C (1999) Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18, 1280-1291.
61. Yu JH, Schaffer DV (2006) High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells. J. Virol. 80, 8981-8988.